Cozen Oconnor
General
Cases684
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
BiotechMech Eng, ManufTransport., E-Comm.
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/06/25 | REDACTION to [154] Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # [1] Exhibit 39)(CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 01/06/25 | REDACTION to [153] Response (NOT Motion),, by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 01/06/25 | MOTION to Seal ECF Nos. 153, 154, and 154-1 by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # [1] Declaration of Charles H. Chevalier, # [2] Index, # [3] Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 01/03/25 | Designation of lead counsel Darin M Klemchuk for Defendant Aborder Products Inc. (Klemchuk, Darin) (Entered: 01/03/2025) | |
| 01/02/25 | SUMMONS ISSUED as to GLAND PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 12/31/24 | Corporate Disclosure Statement by ENDO USA, INC., ENDO OPERATIONS LIMITED identifying Endo, Inc. as Corporate Parent.. (EKINER, KAAN) (Entered: 12/31/2024) | |
| 12/31/24 | COMPLAINT against GLAND PHARMA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15908914), filed by ENDO USA, INC., ENDO OPERATIONS LIMITED. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] Exhibit G, # [8] Exhibit H, # [9] Civil Cover Sheet)(EKINER, KAAN) (Entered: 12/31/2024) | |
| 11/21/24 | ***Civil Case Terminated per Order at [23] . (sm) (Entered: 11/21/2024) |